The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both
Open Access
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (4), 1223-1229
- https://doi.org/10.1111/j.1365-2141.2000.02502.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C ResistanceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The G20210A Mutation of the Prothrombin Gene in Patients with Previous First Episodes of Deep-Vein Thrombosis: Prevalence and Association with Factor V G1691A, Methylenetetrahydrofolate Reductase C677T and Plasma Prothrombin LevelsThrombosis Research, 1999
- Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin GeneArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- RE: "VALIDATED QUESTONNAIRE FOR THE INDENTIFICATION OF PREVIOUS PERSONAL OR FAMILAL VENOUS THROMBOEMBOLISM'American Journal of Epidemiology, 1998
- Validated Questionnaire for the Identification of Previous Personal or Familial Venous ThromboembolismAmerican Journal of Epidemiology, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenThe New England Journal of Medicine, 1995
- Characterization of the Molecular Defect in Factor VR506AOnline Journal of Public Health Informatics, 1995
- Resistance to Activated Protein C as a Basis for Venous ThrombosisThe New England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defectThe Lancet, 1993